Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A

Published:2018-01-12 Issue:3 Volume:22 Page:1909-1922
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Xu Qingqing¹^ORCID,Liu Xiaofei¹,Zhu Shiqin¹,Hu Xuelei¹,Niu Huanmin¹,Zhang Xiulei¹,Zhu Deyu¹,Nesa Effat Un¹,Tian Keli¹,Yuan Huiqing¹

Affiliation:

1. Department of Biochemistry and Molecular Biology; Shandong University School of Medicine; Jinan China

Funder

973 Program

National Natural Science Foundation of China

Shandong Scientific Technology Program

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcmm.13475/fullpdf

Reference38 articles.

1. Sequencing of agents in castration-resistant prostate cancer;Lorente;Lancet Oncol,2015

2. Drug resistance in metastatic castration-resistant prostate cancer;Seruga;Nat Rev Clin Oncol,2011

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Androgen receptors in hormone-dependent and castration-resistant prostate cancer;Shafi;Pharmacol Ther,2013

5. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy;Weichert;Br J Cancer,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting epigenetic targets to overcome taxane resistance in prostate cancer;Cell Death & Disease;2024-02-12

2. The endoplasmic reticulum stress response in prostate cancer;Nature Reviews Urology;2022-09-27

3. From Therapy Resistance to Targeted Therapies in Prostate Cancer;Frontiers in Oncology;2022-05-24

4. Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines;Nanotoxicology;2022-04-21

5. The paradigm of drug resistance in cancer: an epigenetic perspective;Bioscience Reports;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3